stars 1 stars 2 stars 3

Specialties: Search of Investors for Life Sciences and Medtech Companies Facilitating Outlicense, Joint Ventures, M&A Specific business development related with pharma, biotech and medtech IP trade and negotiation We are based both in Spain and Israel and our clients are around the world, including: United States, United Kingdom, France, Israel, Spain, India, China, Hong-Kong. Minimal Transaction Requirements : Drug Development-2M euro, protected IP, Proof of concept in animals. Medtech:-2 M euro, Working Beta prototype, protected IP. Our experience ranges from start-ups and spin-offs to PIPE in Nasdaq quoted Companies, phase III transactions. We also do fundraising for incubators, funds and operations between funds specialized in Life Sciences. Team experience: more than 40 accumulated years; Company funded in 2003 Contact: info (at) kerentech.com

Kerentech Questions

The Kerentech annual revenue was $1 million in 2026.

Esther Mendelsohn is the Partner of Kerentech.

1 people are employed at Kerentech.

The NAICS codes for Kerentech are [541713, 54, 54171, 541, 5417].

The SIC codes for Kerentech are [87, 873].

Top Kerentech Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users